title: In vitro effects of estrogen on tgb and c-myc gene expression in normal and neoplastic human thyroids.
abstract: The authors investigated the effects of 17 beta-estradiol (E) and thyroid-stimulating hormone (TSH) on tgb (coding for thyroglobulin), c-myc RNA levels, and [3H]thymidine (thy) incorporation in suspension cultures of normal, adenomatous and carcinomatous human thyroid follicles. The cultured follicles showed decreased tgb RNA and enhanced c-myc RNA levels. In the culture of normal and adenomatous samples E caused a significant increase of [3H]thy incorporation and tgb RNA levels, with no effect on c-myc RNA levels. No effect of E was observed in the carcinomatous thyroid culture. TSH induced a significant increase of [3H]thy incorporation and c-myc expression only in adenoma cultures and a significant increase of tgb RNA levels in both normal and adenomatous samples. TSH had no effect on the carcinoma. The results show that E, like TSH, stimulates in vitro the expression of the tgb gene in differentiated cells, without stimulating the expression of the c-myc proto-oncogene, suggesting a possible action of E on normal thyroid function and perhaps growth, even if not associated with increased c-myc expression.
authors: Istituto di Chimica Biologica, Università degli Studi, Ferrara, Italy.
authors: L
authors: L
authors: del Senno
authors: E
authors: E
authors: degli Uberti
authors: S
authors: S
authors: Hanau
authors: R
authors: R
authors: Piva
authors: R
authors: R
authors: Rossi
authors: G
authors: G
authors: Trasforini
mesh_terms: D002455:Cell Division; D002471:Cell Transformation, Neoplastic; D004247:DNA / Q000096:biosynthesis; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D007399:Interphase; D009693:Nucleic Acid Hybridization; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc; D012313:RNA / Q000032:analysis / Q000187:drug effects / Q000235:genetics; D013936:Thymidine / Q000378:metabolism; D013954:Thyroglobulin / Q000235:genetics*; D013961:Thyroid Gland / Q000166:cytology / Q000378:metabolism*; D013964:Thyroid Neoplasms / Q000378:metabolism* / Q000473:pathology; D013972:Thyrotropin / Q000494:pharmacology
chemical_list: D004967:Estrogens; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D004958:Estradiol; D012313:RNA; D013972:Thyrotropin; D004247:DNA; D013954:Thyroglobulin; D013936:Thymidine